Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Alcon Drags Down Novartis’s Emerging Markets Performance

This article was originally published in PharmAsia News

Executive Summary

Novartis's performance in emerging markets slowed in the third quarter, due mainly to a slowdown in Asia and the sluggish results of Alcon, which was hit by weaker surgical equipment sales in the sector. Alcon is aiming to turn things around with revitalized leadership and a growth acceleration plan.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register